Telehealth-encouraging VETS Act passes Senate

Veterans across America are one step closer to receiving care through telehealth due to the Veterans E-Health & Telemedicine Support (VETS) Act, which passed the Senate with bipartisan support.

“The VETS Act will help Hawaii veterans access high quality VA care and health services when they need it, where they need it,” said Senator Hirono. “I urge the swift enactment of the bill and will continue to fight to ensure Hawaii veterans can access the care they need from a strong, well-resourced VA system.”

Introduced in 2015 by Senators Joni Ernst, R-Iowa, and Mazie Hirono, D-Hawaii, the VETS Act aims to improve veterans access to telehealth services, including mental health treatments, provided by the Department of Veterans Affairs (VA). The act allows VA health officials to practice across state lines, increasing the availability of telehealth services to veterans residing in rural areas. Additionally, the VA and Congress will provide oversight of the telehealth program by requiring the VA to collect data on the effectiveness of the program.

“All of our veterans must have access to quality and timely care, including life-saving mental health treatment, regardless of where they live,” said Ernst. “The VETS Act would allow Iowa’s rural or disabled veterans to receive care from their own home by increasing telehealth and telemedicine services provided by the VA. With more than 200,000 veterans across Iowa, I am thrilled to see our bipartisan effort advance through the U.S. Senate so we can continue working to ensure better care for those who have sacrificed so much.”

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met. 

When regulating AI-equipped medical devices, the FDA might take a page from the Department of Transportation’s playbook for overseeing AI-equipped vehicles. These run the gamut from assisting human drivers to fully taking the wheel.